BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37955908)

  • 1. Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial.
    Krim SR; Anand S; Greene SJ; Chen A; Wojdyla D; Vilaro J; Haught H; Herre JM; Eisenstein EL; Anstrom KJ; Pitt B; Velazquez EJ; Mentz RJ
    JAMA Cardiol; 2024 Feb; 9(2):182-188. PubMed ID: 37955908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
    Greene SJ; Velazquez EJ; Anstrom KJ; Clare RM; DeWald TA; Psotka MA; Ambrosy AP; Stevens GR; Rommel JJ; Alexy T; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Eisenstein EL; Mentz RJ;
    Circulation; 2023 Jul; 148(2):124-134. PubMed ID: 37212600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
    Mentz RJ; Anstrom KJ; Eisenstein EL; Sapp S; Greene SJ; Morgan S; Testani JM; Harrington AH; Sachdev V; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Velazquez EJ;
    JAMA; 2023 Jan; 329(3):214-223. PubMed ID: 36648467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure - insights from TRANSFORM-HF.
    Martens P; Greene SJ; Mentz RJ; Li S; Wojdyla D; Kapelios CJ; Mullens W; Hall ME; Ketema F; Kim DY; Eisenstein EL; Anstrom K; Fang JC; Pitt B; Velazquez EJ; Tang WHW
    Eur J Heart Fail; 2024 May; 26(5):1242-1250. PubMed ID: 38558520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Furosemide Versus Torsemide on Hospitalizations and Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
    Singh S; Goel S; Duhan S; Chaudhary R; Garg A; Tantry US; Gurbel PA
    Am J Cardiol; 2023 Nov; 206():42-48. PubMed ID: 37677884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HF.
    Kapelios CJ; Greene SJ; Mentz RJ; Ikeaba U; Wojdyla D; Anstrom KJ; Eisenstein EL; Pitt B; Velazquez EJ; Fang JC;
    Circ Heart Fail; 2024 Mar; 17(3):e011246. PubMed ID: 38436075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effect of Loop Diuretic Prescription on Mortality and Heart Failure Readmission.
    Virkud AV; Chang PP; Funk MJ; Kshirsagar AV; Edwards JK; Pate V; Kosorok MR; Gower EW
    Am J Cardiol; 2024 Jan; 210():208-216. PubMed ID: 37972425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF.
    Kittipibul V; Mentz RJ; Clare RM; Wojdyla DM; Anstrom KJ; Eisenstein EL; Ambrosy AP; Goyal P; Skopicki HA; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Velazquez EJ; Greene SJ
    Eur J Heart Fail; 2024 May; ():. PubMed ID: 38745502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes With Furosemide Versus Torsemide in Patients With Heart Failure: An Updated Systematic Review and Meta-Analysis.
    Siddiqi AK; Javaid H; Ahmed M; Dhawadi S; Batool L; Zahid M; Muslim MO; Naeem K; Mahmood F; Hussain A
    Curr Probl Cardiol; 2023 Nov; 48(11):101927. PubMed ID: 37453532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive review of the loop diuretics: should furosemide be first line?
    Wargo KA; Banta WM
    Ann Pharmacother; 2009 Nov; 43(11):1836-47. PubMed ID: 19843838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of torsemide in patients with heart failure and renal disease.
    Peters AE; Mentz RJ; DeWald TA; Greene SJ
    Expert Rev Cardiovasc Ther; 2022 Jan; 20(1):5-11. PubMed ID: 34936522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy.
    Mallick A; Gandhi PU; Gaggin HK; Ibrahim N; Januzzi JL
    JACC Heart Fail; 2016 Sep; 4(9):749-55. PubMed ID: 27179830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization.
    Imaeda S; Shiraishi Y; Kohsaka S; Niimi N; Goda A; Nagatomo Y; Takei M; Saji M; Nakano S; Kohno T; Fukuda K; Yoshikawa T
    ESC Heart Fail; 2022 Oct; 9(5):2967-2977. PubMed ID: 35730147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial.
    Greene SJ; Velazquez EJ; Anstrom KJ; Eisenstein EL; Sapp S; Morgan S; Harding T; Sachdev V; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Mentz RJ;
    JACC Heart Fail; 2021 May; 9(5):325-335. PubMed ID: 33714745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
    Miles JA; Hanumanthu BK; Patel K; Chen M; Siegel RM; Kokkinidis DG
    J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):379-388. PubMed ID: 30950982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
    Mentz RJ; Hasselblad V; DeVore AD; Metra M; Voors AA; Armstrong PW; Ezekowitz JA; Tang WH; Schulte PJ; Anstrom KJ; Hernandez AF; Velazquez EJ; O'Connor CM
    Am J Cardiol; 2016 Feb; 117(3):404-11. PubMed ID: 26704029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
    Ozierański K; Balsam P; Kapłon-Cieślicka A; Tymińska A; Kowalik R; Grabowski M; Peller M; Wancerz A; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):77-86. PubMed ID: 30649675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing torsemide versus furosemide in patients with heart failure: A meta-analysis.
    Kido K; Shimizu M; Hashiguchi M
    J Am Pharm Assoc (2003); 2019; 59(3):432-438. PubMed ID: 30846351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
    Rahhal A; Saad MO; Tawengi K; Assi AAR; Habra M; Ahmed D
    BMC Cardiovasc Disord; 2019 May; 19(1):127. PubMed ID: 31138146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure.
    Abraham B; Megaly M; Sous M; Fransawyalkomos M; Saad M; Fraser R; Topf J; Goldsmith S; Simegn M; Bart B; Azzo Z; Mesiha N; Sharma R
    Am J Cardiol; 2020 Jan; 125(1):92-99. PubMed ID: 31699358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.